Sugar-sweetened beverages and prevalence of the metabolically abnormal phenotype in the Framingham Heart Study

Obesity

Volumn 22, Issue 5, 2014, Pages

  Green, Angela K ^a   Jacques, Paul F ^b,c   Rogers, Gail ^b   Fox, Caroline S ^d,e   Meigs, James B ^f   McKeown, Nicola M ^b,c  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b TUFTS UNIVERSITY   (United States)

^c TUFTS UNIVERSITY   (United States)

^d FRAMINGHAM HEART STUDY   (United States)

^e BRIGHAM AND WOMEN S HOSPITAL   (United States)

^f MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

chronic disease; metabolically healthy obese phenotype; Obesity; sugar sweetened beverages

Indexed keywords

GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; GLUCOSE BLOOD LEVEL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; SUGAR INTAKE; SWEETENING AGENT;

ADULT; AGED; ARTICLE; BEVERAGE; BODY MASS; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; FEMALE; FOOD INTAKE; HEALTH STATUS; HUMAN; HYPERTENSION; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; METABOLIC DISORDER; OBESITY; PATIENT ASSESSMENT; PHENOTYPE; PREVALENCE; RISK ASSESSMENT; SUGAR SWEETENED BEVERAGE; ADMINISTRATION AND DOSAGE; ANALYSIS; BLOOD; BODY WEIGHT; CALORIC INTAKE; EPIDEMIOLOGY; FEEDING BEHAVIOR; GLUCOSE BLOOD LEVEL; METABOLIC SYNDROME X; METABOLISM; MIDDLE AGED; MULTIVARIATE ANALYSIS; NUTRITIONAL ASSESSMENT; STATISTICAL MODEL; SUGAR INTAKE; UNITED STATES;

ADULT; BEVERAGES; BLOOD GLUCOSE; BODY MASS INDEX; BODY WEIGHT; CHOLESTEROL, HDL; CHOLESTEROL, LDL; CROSS-SECTIONAL STUDIES; DIETARY SUCROSE; ENERGY INTAKE; FEEDING BEHAVIOR; FEMALE; HUMANS; INSULIN RESISTANCE; LOGISTIC MODELS; MALE; MASSACHUSETTS; METABOLIC SYNDROME X; MIDDLE AGED; MULTIVARIATE ANALYSIS; NUTRITION ASSESSMENT; OBESITY; PHENOTYPE; PREVALENCE; SWEETENING AGENTS; TRIGLYCERIDES;

EID: 84899988517     PISSN: 19307381     EISSN: 1930739X     Source Type: Journal    
DOI: 10.1002/oby.20724     Document Type: Article

References (36)

1. Malik VS, Popkin BM, Bray GA, Despres JP, Willett WC, Hu FB,. Sugar-sweetened beverages and risk of metabolic syndrome and type 2 diabetes: a meta-analysis. Diabetes Care 2010; 33: 2477-2483.
2. Fung TT, Malik V, Rexrode KM, Manson JE, Willett WC, Hu FB,. Sweetened beverage consumption and risk of coronary heart disease in women. Am J Clin Nutr 2009; 89: 1037-1042.
3. de Koning L, Malik VS, Kellogg MD, Rimm EB, Willett WC, Hu FB,. Sweetened beverage consumption, incident coronary heart disease, and biomarkers of risk in men. Circulation 2012; 125: 1735-1741, S1.
4. Barrio-Lopez MT, Martinez-Gonzalez MA, Fernandez-Montero A, Beunza JJ, Zazpe I, Bes-Rastrollo M,. Prospective study of changes in sugar-sweetened beverage consumption and the incidence of the metabolic syndrome and its components: the SUN cohort. Br J Nutr 2013: 1-10.
5. Yoshida M, McKeown NM, Rogers G, et al. Surrogate markers of insulin resistance are associated with consumption of sugar-sweetened drinks and fruit juice in middle and older-aged adults. J Nutr 2007; 137: 2121-2127.
6. Dhingra R, Sullivan L, Jacques PF, et al. Soft drink consumption and risk of developing cardiometabolic risk factors and the metabolic syndrome in middle-aged adults in the community. Circulation 2007; 116: 480-488.
7. Flegal KM, Carroll MD, Kit BK, Ogden CL,. Prevalence of obesity and trends in the distribution of body mass index among US adults, 1999-2010. JAMA 2012; 307: 491-497.
8. Flegal KM, Carroll MD, Ogden CL, Curtin LR,. Prevalence and trends in obesity among US adults, 1999-2008. JAMA 2010; 303: 235-241.
9. Karelis AD, Brochu M, Rabasa-Lhoret R,. Can we identify metabolically healthy but obese individuals (MHO)? Diabetes Metab 2004; 30: 569-572.
10. Bonora E, Kiechl S, Willeit J, et al. Prevalence of insulin resistance in metabolic disorders: the Bruneck Study. Diabetes 1998; 47: 1643-1649.
11. Brochu M, Tchernof A, Dionne IJ, et al. What are the physical characteristics associated with a normal metabolic profile despite a high level of obesity in postmenopausal women? J Clin Endocrinol Metab 2001; 86: 1020-1025.
12. Ferrannini E, Haffner SM, Mitchell BD, Stern MP,. Hyperinsulinaemia: the key feature of a cardiovascular and metabolic syndrome. Diabetologia 1991; 34: 416-422.
13. Bluher M,. The distinction of metabolically 'healthy' from 'unhealthy' obese individuals. Curr Opin Lipidol 2010; 21: 38-43.
14. Wildman RP, Muntner P, Reynolds K, et al. The obese without cardiometabolic risk factor clustering and the normal weight with cardiometabolic risk factor clustering: prevalence and correlates of 2 phenotypes among the US population (NHANES 1999-2004). Arch Intern Med 2008; 168: 1617-1624.
15. Aguilar-Salinas CA, Garcia EG, Robles L, et al. High adiponectin concentrations are associated with the metabolically healthy obese phenotype. J Clin Endocrinol Metab 2008; 93: 4075-4079.
16. Karelis AD, Faraj M, Bastard JP, et al. The metabolically healthy but obese individual presents a favorable inflammation profile. J Clin Endocrinol Metab 2005; 90: 4145-4150.
17. Hamer M, Stamatakis E,. Metabolically healthy obesity and risk of all-cause and cardiovascular disease mortality. J Clin Endocrinol Metab 2012; 97: 2482-2488.
18. Kramer CK, Zinman B, Retnakaran R,. Are metabolically healthy overweight and obesity benign conditions?: A systematic review and meta-analysis. Ann Intern Med 2013; 159: 758-769.
19. Hankinson AL, Daviglus ML, Van Horn L, et al. Diet composition and activity level of at risk and metabolically healthy obese American adults. Obesity (Silver Spring) 2013; 21: 637-643.
20. Phillips CM, Dillon C, Harrington JM, et al. Defining metabolically healthy obesity: role of dietary and lifestyle factors. PloS One 2013; 8: e76188.
21. Bradshaw PT, Monda KL, Stevens J,. Metabolic syndrome in healthy obese, overweight, and normal weight individuals: the Atherosclerosis Risk in Communities Study. Obesity (Silver Spring) 2013; 21: 203-209.
22. Dawber TR, Meadors GF, Moore FE, Jr,. Epidemiological approaches to heart disease: the Framingham Study. Am J Public Health Nations Health 1951; 41: 279-281.
23. Feinleib M, Kannel WB, Garrison RJ, McNamara PM, Castelli WP,. The Framingham Offspring Study. Design and preliminary data. Prev Med 1975; 4: 518-525.
24. Rimm EB, Giovannucci EL, Stampfer MJ, Colditz GA, Litin LB, Willett WC,. Reproducibility and validity of an expanded self-administered semiquantitative food frequency questionnaire among male health professionals. Am J Epidemiol 1992; 135: 1114-1126; discussion 27-36.
25. Willett WC, Sampson L, Stampfer MJ, et al. Reproducibility and validity of a semiquantitative food frequency questionnaire. Am J Epidemiol 1985; 122: 51-65.
26. Feskanich D, Rimm EB, Giovannucci EL, et al. Reproducibility and validity of food intake measurements from a semiquantitative food frequency questionnaire. J Am Diet Assoc 1993; 93: 790-796.
27. Salvini S, Hunter DJ, Sampson L, et al. Food-based validation of a dietary questionnaire: the effects of week-to-week variation in food consumption. Int J Epidemiol 1989; 18: 858-867.
28. Hu FB, Rimm E, Smith-Warner SA, et al. Reproducibility and validity of dietary patterns assessed with a food-frequency questionnaire. Am J Clin Nutr 1999; 69: 243-249.
29. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001; 285: 2486-2497.
30. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC,. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412-419.
31. Rutter MK, Wilson PW, Sullivan LM, Fox CS, D'Agostino RB, Sr., Meigs JB., Use of alternative thresholds defining insulin resistance to predict incident type 2 diabetes mellitus and cardiovascular disease. Circulation 2008; 117: 1003-1009.
32. Neeland IJ, Turer AT, Ayers CR, et al. Dysfunctional adiposity and the risk of prediabetes and type 2 diabetes in obese adults. JAMA 2012; 308: 1150-1159.
33. Ma J, Sloan M, Fox CS, Hoffman U, Jacques PF, McKeown NM,. Sugar-sweetened beverage consumption is associated with relative distribution of abdominal adipose tissue in the Framingham Heart Study. Experimental Biology Conference. Boston, MA: 2013.
34. Qi Q, Chu AY, Kang JH, et al. Sugar-sweetened beverages and genetic risk of obesity. N Engl J Med 2012; 367: 1387-1396.
35. Ortega FB, Lee DC, Katzmarzyk PT, et al. The intriguing metabolically healthy but obese phenotype: cardiovascular prognosis and role of fitness. Eur Heart J 2013; 34: 389-397.
36. Pataky Z, Bobbioni-Harsch E, Golay A,. Open questions about metabolically normal obesity. Int J Obes (Lond) 2010; 34 Suppl 2: S18-S23.